April 14, 2026
\n12:10\u2013 1:10 p.m. PDT
\nSAC 147 or\u00a0Zoom<\/a><\/h3>\nAbstract Presentation<\/h4>\n
The microbiome comprises not only bacteria but also fungi, parasites, and viruses that can have profound biological effects on one another and on the host. Here, I will describe our work looking at interactions between the fungus Candida albicans and the bacterium Enterococcus faecalis, two opportunistic pathogens that share host niches in both commensal and diseased states. We discovered that these two bugs inhibit each other\u2019s pathogenicity and will describe our studies elucidating the secreted molecules that mediate these effects, as well as our efforts to apply this knowledge to develop new anti-infective therapeutics.<\/p>\n
![\"Danielle](\"https:\/\/wpcdn.web.wsu.edu\/wp-medicine\/uploads\/sites\/3023\/2026\/03\/Danielle-Garsin-396x536.jpg\")
<\/h4>\nSpeaker<\/h4>\n
Danielle A. Garsin, PhD<\/strong>
\nProfessor; McGovern Medical School part of UTHealth-Houston
\nThe University of Texas Health Science Center at Houston Department of Microbiology and Molecular Genetics<\/p>\nDr. Garsin is a professor of Microbiology and Molecular Genetics at the University of Texas Health Science Center at Houston. Dr. Garsin received her Ph.D. in Biochemistry from Harvard University and her B.S. in Biological Sciences from Cornell University. Dr. Garsin is interested in microbial pathogenesis, gene regulation, host-microbe, and microbe-microbe interactions. One NIH-funded research focus is on the roles and regulation of ethanolamine utilization in bacteria. Another concerns the biology of the immune responses elicited in the model host, Caenorhabditis elegans. Finally, Dr. Garsin studies the interactions between Enterococcus faecalis and the human fungal pathogen Candida albicans; the discovery that the microbes inhibit each other\u2019s virulence has led to the development of molecules with anti-infective therapeutic potential. Dr. Garsin has received many commendations for excellence in research and education. She earned an Ellison Medical Foundation New Scholar Award in Global Infectious Disease, a UT System STAR award, the Dean\u2019s Teaching Excellence Award in multiple years, and was elected as a Fellow to the American Academy for Microbiology. She has served the scientific community as a permanent member of the Prokaryotic Cell and Molecular Biology (PCMB) and Innate Immunity and Inflammation (III) NIH review groups and as an editor of PLOS Genetics and mBio.<\/p>\n","protected":false},"excerpt":{"rendered":"
Speaker: Danielle A. Garsin, PhD, Professor; McGovern Medical School part of UTHealth-Houston, The University of Texas Health Science Center at Houston Department of Microbiology and Molecular Genetics.<\/p>\n","protected":false},"author":34189,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_wsuwp_accessibility_report":[],"_tribe_events_status":"","_tribe_events_status_reason":""},"tags":[],"tribe_events_cat":[],"wsuwp_university_location":[],"wsuwp_university_org":[],"event_city":"Spokane","event_state":"WA","event_venue":"SAC 147","event_organizer":"","event_organizer_email":"","event_organizer_phone":"","event_organizer_website":"","event_website":"","event_cost":"","event_excerpt":"Presented by Washington State University \u2013 Department of Translational Medicine & Physiology\nEnterococcus faecalis and Candida albicans Inter-Kingdom Interactions\nApril 14, 2026\n12:10\u2013 1:10 p.m. PDT\nSAC 147 or\u00a0Zoom\nAbstract Presentation\nThe microbiome comprises not only bacteria but also fungi, parasites, and viruses that can have profound biological effects on one another and on the host. Here, I will describe our work looking at interactions between the fungus Candida albicans and the bacterium Enterococcus faecalis, two opportunistic pathogens that share host niches in both commensal and diseased states. We discovered that these two bugs inhibit each other\u2019s pathogenicity and will describe our studies elucidating the secreted molecules that mediate these effects, as well as our efforts to apply this knowledge to develop new anti-infective therapeutics.\n\nSpeaker\nDanielle A. Garsin, PhD\nProfessor; McGovern Medical School part of UTHealth-Houston\nThe University of Texas Health Science Center at Houston Department of Microbiology and Molecular Genetics\nDr. Garsin is a professor of Microbiology and Molecular Genetics at the University of Texas Health Science Center at Houston. Dr. Garsin received her Ph.D. in Biochemistry from Harvard University and her B.S. in Biological Sciences from Cornell University. Dr. Garsin is interested in microbial pathogenesis, gene regulation, host-microbe, and microbe-microbe interactions. One NIH-funded research focus is on the roles and regulation of ethanolamine utilization in bacteria. Another concerns the biology of the immune responses elicited in the model host, Caenorhabditis elegans. Finally, Dr. Garsin studies the interactions between Enterococcus faecalis and the human fungal pathogen Candida albicans; the discovery that the microbes inhibit each other\u2019s virulence has led to the development of molecules with anti-infective therapeutic potential. Dr. Garsin has received many commendations for excellence in research and education. She earned an Ellison Medical Foundation New Scholar Award in Global Infectious Disease, a UT System STAR award, the Dean\u2019s Teaching Excellence Award in multiple years, and was elected as a Fellow to the American Academy for Microbiology. She has served the scientific community as a permanent member of the Prokaryotic Cell and Molecular Biology (PCMB) and Innate Immunity and Inflammation (III) NIH review groups and as an editor of PLOS Genetics and mBio.","start_date":"2026-04-14 12:10:00","end_date":"2026-04-14 13:10:00","_links":{"self":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events\/36145"}],"collection":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events"}],"about":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/users\/34189"}],"replies":[{"embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/comments?post=36145"}],"version-history":[{"count":4,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events\/36145\/revisions"}],"predecessor-version":[{"id":36197,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events\/36145\/revisions\/36197"}],"wp:attachment":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/media?parent=36145"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/tags?post=36145"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/tribe_events_cat?post=36145"},{"taxonomy":"wsuwp_university_location","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/wsuwp_university_location?post=36145"},{"taxonomy":"wsuwp_university_org","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/wsuwp_university_org?post=36145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/h4>\nSpeaker<\/h4>\n
\nProfessor; McGovern Medical School part of UTHealth-Houston
\nThe University of Texas Health Science Center at Houston Department of Microbiology and Molecular Genetics<\/p>\n
Dr. Garsin is a professor of Microbiology and Molecular Genetics at the University of Texas Health Science Center at Houston. Dr. Garsin received her Ph.D. in Biochemistry from Harvard University and her B.S. in Biological Sciences from Cornell University. Dr. Garsin is interested in microbial pathogenesis, gene regulation, host-microbe, and microbe-microbe interactions. One NIH-funded research focus is on the roles and regulation of ethanolamine utilization in bacteria. Another concerns the biology of the immune responses elicited in the model host, Caenorhabditis elegans. Finally, Dr. Garsin studies the interactions between Enterococcus faecalis and the human fungal pathogen Candida albicans; the discovery that the microbes inhibit each other\u2019s virulence has led to the development of molecules with anti-infective therapeutic potential. Dr. Garsin has received many commendations for excellence in research and education. She earned an Ellison Medical Foundation New Scholar Award in Global Infectious Disease, a UT System STAR award, the Dean\u2019s Teaching Excellence Award in multiple years, and was elected as a Fellow to the American Academy for Microbiology. She has served the scientific community as a permanent member of the Prokaryotic Cell and Molecular Biology (PCMB) and Innate Immunity and Inflammation (III) NIH review groups and as an editor of PLOS Genetics and mBio.<\/p>\n","protected":false},"excerpt":{"rendered":"
Speaker: Danielle A. Garsin, PhD, Professor; McGovern Medical School part of UTHealth-Houston, The University of Texas Health Science Center at Houston Department of Microbiology and Molecular Genetics.<\/p>\n","protected":false},"author":34189,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_wsuwp_accessibility_report":[],"_tribe_events_status":"","_tribe_events_status_reason":""},"tags":[],"tribe_events_cat":[],"wsuwp_university_location":[],"wsuwp_university_org":[],"event_city":"Spokane","event_state":"WA","event_venue":"SAC 147","event_organizer":"","event_organizer_email":"","event_organizer_phone":"","event_organizer_website":"","event_website":"","event_cost":"","event_excerpt":"Presented by Washington State University \u2013 Department of Translational Medicine & Physiology\nEnterococcus faecalis and Candida albicans Inter-Kingdom Interactions\nApril 14, 2026\n12:10\u2013 1:10 p.m. PDT\nSAC 147 or\u00a0Zoom\nAbstract Presentation\nThe microbiome comprises not only bacteria but also fungi, parasites, and viruses that can have profound biological effects on one another and on the host. Here, I will describe our work looking at interactions between the fungus Candida albicans and the bacterium Enterococcus faecalis, two opportunistic pathogens that share host niches in both commensal and diseased states. We discovered that these two bugs inhibit each other\u2019s pathogenicity and will describe our studies elucidating the secreted molecules that mediate these effects, as well as our efforts to apply this knowledge to develop new anti-infective therapeutics.\n\nSpeaker\nDanielle A. Garsin, PhD\nProfessor; McGovern Medical School part of UTHealth-Houston\nThe University of Texas Health Science Center at Houston Department of Microbiology and Molecular Genetics\nDr. Garsin is a professor of Microbiology and Molecular Genetics at the University of Texas Health Science Center at Houston. Dr. Garsin received her Ph.D. in Biochemistry from Harvard University and her B.S. in Biological Sciences from Cornell University. Dr. Garsin is interested in microbial pathogenesis, gene regulation, host-microbe, and microbe-microbe interactions. One NIH-funded research focus is on the roles and regulation of ethanolamine utilization in bacteria. Another concerns the biology of the immune responses elicited in the model host, Caenorhabditis elegans. Finally, Dr. Garsin studies the interactions between Enterococcus faecalis and the human fungal pathogen Candida albicans; the discovery that the microbes inhibit each other\u2019s virulence has led to the development of molecules with anti-infective therapeutic potential. Dr. Garsin has received many commendations for excellence in research and education. She earned an Ellison Medical Foundation New Scholar Award in Global Infectious Disease, a UT System STAR award, the Dean\u2019s Teaching Excellence Award in multiple years, and was elected as a Fellow to the American Academy for Microbiology. She has served the scientific community as a permanent member of the Prokaryotic Cell and Molecular Biology (PCMB) and Innate Immunity and Inflammation (III) NIH review groups and as an editor of PLOS Genetics and mBio.","start_date":"2026-04-14 12:10:00","end_date":"2026-04-14 13:10:00","_links":{"self":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events\/36145"}],"collection":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events"}],"about":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/users\/34189"}],"replies":[{"embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/comments?post=36145"}],"version-history":[{"count":4,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events\/36145\/revisions"}],"predecessor-version":[{"id":36197,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/events\/36145\/revisions\/36197"}],"wp:attachment":[{"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/media?parent=36145"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/tags?post=36145"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/tribe_events_cat?post=36145"},{"taxonomy":"wsuwp_university_location","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/wsuwp_university_location?post=36145"},{"taxonomy":"wsuwp_university_org","embeddable":true,"href":"https:\/\/medicine.wsu.edu\/news\/wp-json\/wp\/v2\/wsuwp_university_org?post=36145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}